JP2002527414A5 - - Google Patents

Download PDF

Info

Publication number
JP2002527414A5
JP2002527414A5 JP2000575820A JP2000575820A JP2002527414A5 JP 2002527414 A5 JP2002527414 A5 JP 2002527414A5 JP 2000575820 A JP2000575820 A JP 2000575820A JP 2000575820 A JP2000575820 A JP 2000575820A JP 2002527414 A5 JP2002527414 A5 JP 2002527414A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
hydrogen
substituted
iodo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000575820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002527414A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/023779 external-priority patent/WO2000021910A2/en
Publication of JP2002527414A publication Critical patent/JP2002527414A/ja
Publication of JP2002527414A5 publication Critical patent/JP2002527414A5/ja
Pending legal-status Critical Current

Links

JP2000575820A 1998-10-14 1999-10-13 1,2−ジ置換シクロプロパン Pending JP2002527414A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10413298P 1998-10-14 1998-10-14
US60/104,132 1998-10-14
PCT/US1999/023779 WO2000021910A2 (en) 1998-10-14 1999-10-13 1,2-disubstituted cyclopropanes

Publications (2)

Publication Number Publication Date
JP2002527414A JP2002527414A (ja) 2002-08-27
JP2002527414A5 true JP2002527414A5 (US07794700-20100914-C00152.png) 2006-12-21

Family

ID=22298823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000575820A Pending JP2002527414A (ja) 1998-10-14 1999-10-13 1,2−ジ置換シクロプロパン

Country Status (5)

Country Link
US (1) US6172091B1 (US07794700-20100914-C00152.png)
JP (1) JP2002527414A (US07794700-20100914-C00152.png)
AU (1) AU760889B2 (US07794700-20100914-C00152.png)
CA (1) CA2347092A1 (US07794700-20100914-C00152.png)
WO (1) WO2000021910A2 (US07794700-20100914-C00152.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809396B1 (fr) 2000-05-24 2005-10-14 Centre Nat Rech Scient Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
US6908935B2 (en) 2002-05-23 2005-06-21 Amgen Inc. Calcium receptor modulating agents
US7176322B2 (en) 2002-05-23 2007-02-13 Amgen Inc. Calcium receptor modulating agents
TR201910177T4 (tr) 2003-09-12 2019-08-21 Amgen Inc Bir sinakalset HCl içeren hızlı çözünme formülasyonu.
WO2005065050A2 (ja) 2003-12-25 2005-07-21 Asahi Kasei Pharma Corporation 2環化合物
WO2005115975A1 (ja) 2004-05-28 2005-12-08 Tanabe Seiyaku Co., Ltd. アリールアルキルアミン化合物及びその製法
EA200701745A1 (ru) 2005-03-17 2008-06-30 Пфайзер, Инк. Циклопропанкарбоксамидные производные
AU2006227429A1 (en) * 2005-03-17 2006-09-28 Amgen Inc. Methods of decreasing calcification
JP5309014B2 (ja) * 2006-03-23 2013-10-09 アムジエン・インコーポレーテツド シナカルセットの多形体の製造および使用のための方法および組成物
KR20080110681A (ko) * 2006-04-20 2008-12-18 암겐 인코포레이티드 안정적 에멀젼 조제물
US7743661B2 (en) * 2006-04-26 2010-06-29 Halliburton Energy Services, Inc. Fiber optic MEMS seismic sensor with mass supported by hinged beams
EP2139462B1 (en) 2007-03-30 2014-01-22 Amgen Inc. Calcimimetic compounds for use in the treatment of bowel disorders
WO2010104882A1 (en) 2009-03-10 2010-09-16 Amgen Inc. Methods of modulating sperm motility
WO2010136035A2 (en) 2009-05-27 2010-12-02 Leo Pharma A/S Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
WO2010136037A1 (en) 2009-05-27 2010-12-02 Leo Pharma A/S Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
US8497271B2 (en) * 2009-10-07 2013-07-30 Bristol-Myers Squibb Company Modulators of G protein-coupled receptor 88
WO2012000498A1 (en) 2010-06-30 2012-01-05 Leo Pharma A/S New polymorphic form of a calcimimetic compound
RU2599788C2 (ru) 2010-06-30 2016-10-20 Лео Фарма А/С Новая полиморфная форма кальцимиметического соединения
US20130245084A1 (en) 2010-11-26 2013-09-19 Leo Pharma A/S Calcium-sensing receptor-active compounds
WO2012069420A2 (en) 2010-11-26 2012-05-31 Leo Pharma A/S Calcium-sensing receptor-active compounds
US20130261132A1 (en) 2010-11-26 2013-10-03 Leo Pharma A/S Calcium-sensing receptor-active compounds
JP2014500882A (ja) 2010-11-26 2014-01-16 レオ ファーマ アクティーゼルスカブ カルシウム感知受容体活性化合物
US20150315130A1 (en) * 2012-12-10 2015-11-05 H. Lundbeck A/S New positive allosteric modulators of nicotinic acetylcholine receptor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802981A1 (de) 1988-02-02 1989-08-10 Basf Ag Verfahren zur reduktion reduzierbarer verbindungen
FR2636625B1 (fr) 1988-09-01 1990-11-09 Jouveinal Sa Benzylamines disubstituees, leur procede de preparation, leur utilisation comme medicament et leurs intermediaires de synthese
US5169780A (en) 1989-06-22 1992-12-08 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
ATE312347T1 (de) 1991-08-23 2005-12-15 Nps Pharma Inc Screening-verfahren für kalzium-rezeptor aktive verbindungen
US6071970A (en) 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE69333527T2 (de) 1993-02-23 2005-06-16 Brigham & Women's Hospital, Inc., Boston Calciumrezeptoraktive moleküle
ES2156162T3 (es) 1994-02-08 2001-06-16 Nps Pharma Inc Compuestos activos en un nuevo sitio sobre canales del calcio accionados por un receptor, utiles para el tratamiento de trastornos y enfermedades neurologicas.
US5504253A (en) 1994-07-15 1996-04-02 Nps Pharmaceuticals, Inc. Amine preparation
AU3414295A (en) 1994-08-19 1996-03-14 Nps Pharmaceuticals, Inc. Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases
UA55374C2 (uk) 1994-10-21 2003-04-15 Нпс Фармасьютікалз, Інк Сполуки, що мають активність по відношенню до рецепторів кальцію
CA2176854A1 (en) * 1995-06-07 1996-12-08 Daniel J. Keavy N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
US5753709A (en) 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics

Similar Documents

Publication Publication Date Title
JP2002527414A5 (US07794700-20100914-C00152.png)
JP2002030084A5 (US07794700-20100914-C00152.png)
CA2436846A1 (en) Thioether substituted imidazoquinolines
JP2003519676A5 (US07794700-20100914-C00152.png)
JP2004516314A5 (US07794700-20100914-C00152.png)
JP2007510619A5 (US07794700-20100914-C00152.png)
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2007520440A5 (US07794700-20100914-C00152.png)
JP2002541233A5 (US07794700-20100914-C00152.png)
JP2003531118A5 (US07794700-20100914-C00152.png)
JP2004505047A5 (US07794700-20100914-C00152.png)
JP2008511601A5 (US07794700-20100914-C00152.png)
JP2002520416A5 (US07794700-20100914-C00152.png)
JP2007530694A5 (US07794700-20100914-C00152.png)
JP2002540208A5 (US07794700-20100914-C00152.png)
JP2018135343A5 (US07794700-20100914-C00152.png)
NZ515282A (en) Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
JP2004500426A5 (US07794700-20100914-C00152.png)
JP2005526836A5 (US07794700-20100914-C00152.png)
JP2005511547A5 (US07794700-20100914-C00152.png)
JP2002520316A5 (US07794700-20100914-C00152.png)
JP2005539045A5 (US07794700-20100914-C00152.png)
JP2002518502A5 (US07794700-20100914-C00152.png)
JP2003502367A5 (US07794700-20100914-C00152.png)
JP2004532185A5 (US07794700-20100914-C00152.png)